These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12637159)
1. ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction. Hara Y; Zheng Z; Evans SC; Malatjalian D; Riddell DC; Guernsey DL; Wang LD; Riabowol K; Casson AG Cancer Lett; 2003 Mar; 192(1):109-16. PubMed ID: 12637159 [TBL] [Abstract][Full Text] [Related]
2. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. Oki E; Maehara Y; Tokunaga E; Kakeji Y; Sugimachi K Cancer Lett; 1999 Dec; 147(1-2):157-62. PubMed ID: 10660101 [TBL] [Abstract][Full Text] [Related]
3. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410 [TBL] [Abstract][Full Text] [Related]
4. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas. Takahashi M; Ozaki T; Todo S; Nakagawara A Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504 [TBL] [Abstract][Full Text] [Related]
5. [Effects of two variants of ING1 expression on tumor cell growth regulation]. Liu JY; Wu BQ; Zheng J; You JF; Zhong HH; Wang JL Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):48-51. PubMed ID: 12760804 [TBL] [Abstract][Full Text] [Related]
6. Expression and sequence analyses of p33(ING1) gene in myeloid leukemia. Ito K; Kinjo K; Nakazato T; Ikeda Y; Kizaki M Am J Hematol; 2002 Feb; 69(2):141-3. PubMed ID: 11835353 [TBL] [Abstract][Full Text] [Related]
7. The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines. Campos EI; Cheung KJ; Murray A; Li S; Li G Br J Dermatol; 2002 Apr; 146(4):574-80. PubMed ID: 11966686 [TBL] [Abstract][Full Text] [Related]
8. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors. Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120 [TBL] [Abstract][Full Text] [Related]
9. Relative levels of alternative transcripts of the ING1 gene and lack of mutations of p33/ING1 in haematological malignancies. Bromidge T; Lynas C Leuk Res; 2002 Jul; 26(7):631-5. PubMed ID: 12008079 [TBL] [Abstract][Full Text] [Related]
10. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer. Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670 [TBL] [Abstract][Full Text] [Related]
11. Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers. Tokunaga E; Maehara Y; Oki E; Kitamura K; Kakeji Y; Ohno S; Sugimachi K Cancer Lett; 2000 Apr; 152(1):15-22. PubMed ID: 10754201 [TBL] [Abstract][Full Text] [Related]
12. p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1. Saito A; Furukawa T; Fukushige S; Koyama S; Hoshi M; Hayashi Y; Horii A J Hum Genet; 2000; 45(3):177-81. PubMed ID: 10807544 [TBL] [Abstract][Full Text] [Related]
13. Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex. Skowyra D; Zeremski M; Neznanov N; Li M; Choi Y; Uesugi M; Hauser CA; Gu W; Gudkov AV; Qin J J Biol Chem; 2001 Mar; 276(12):8734-9. PubMed ID: 11118440 [TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma. Krishnamurthy J; Kannan K; Feng J; Mohanprasad BK; Tsuchida N; Shanmugam G Oral Oncol; 2001 Apr; 37(3):222-4. PubMed ID: 11287275 [TBL] [Abstract][Full Text] [Related]
15. Suppression of ING1 expression in sporadic breast cancer. Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868 [TBL] [Abstract][Full Text] [Related]
16. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG. Takahashi M; Seki N; Ozaki T; Kato M; Kuno T; Nakagawa T; Watanabe K; Miyazaki K; Ohira M; Hayashi S; Hosoda M; Tokita H; Mizuguchi H; Hayakawa T; Todo S; Nakagawara A Cancer Res; 2002 Apr; 62(8):2203-9. PubMed ID: 11956069 [TBL] [Abstract][Full Text] [Related]
17. Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer. Chen LS; Wei JB; Zhou YC; Zhang S; Liang JL; Cao YF; Tang ZJ; Zhang XL; Gao F World J Gastroenterol; 2005 Oct; 11(39):6120-4. PubMed ID: 16273637 [TBL] [Abstract][Full Text] [Related]
18. Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues. Nouman GS; Angus B; Lunec J; Crosier S; Lodge A; Anderson JJ Hybrid Hybridomics; 2002 Feb; 21(1):1-10. PubMed ID: 11991811 [TBL] [Abstract][Full Text] [Related]
19. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner. Vieyra D; Toyama T; Hara Y; Boland D; Johnston R; Riabowol K Cancer Res; 2002 Aug; 62(15):4445-52. PubMed ID: 12154053 [TBL] [Abstract][Full Text] [Related]